ASSOCIATION BETWEEN BLOOD UREA NITROGEN/ALBUMIN RATIO AND PROGNOSIS IN NON-SMALL CELL LUNG CANCER
dc.contributor.author | Köş, Mehmet | |
dc.contributor.author | Hocazade, Cemil | |
dc.contributor.author | Köş, Fahriye Tuğba | |
dc.contributor.author | Uncu, Doğan | |
dc.contributor.author | Karakaş, Esra | |
dc.contributor.author | Doğan, Mutlu | |
dc.contributor.author | Zengin, Nurullah | |
dc.date.accessioned | 2020-04-30T22:39:50Z | |
dc.date.available | 2020-04-30T22:39:50Z | |
dc.date.issued | 2015 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | WOS: 000363826100001 | en_US |
dc.description.abstract | Introduction: Prognostic value of easily available and reproducible laboratory parameters is investigated for non-small cell lung cancer (NSCLC) of which mortality is still high. We aimed to determine the prognostic value of blood urea nitrogen/albumin (BUN/albumin) ratio. Methods: ClinicoPathological characteristics with treatment modalities and laboratory values of NSCLC patients at our center evaluated retrospectively. A total of 142 patients were included to the study. Results: Median age was 57 (range 26-83). Receiver operating characteristic (ROC) curves for overall survival prediction were plotted to verify, the optimum cut-off point for BUN/albumin ratio. The recommended cut-off values for BUN/albumin ratio was 0.80 with a sensitivity of 60.0% and a specificity of 60.0%. While median overall survival was 26.0 (95% CI: 14.2-37.7) months in the group with low BUN/albumin ratio (<0.80), it was Calculated as 10.0 (95% CI: 5.2-14.8) months in the group with high BUN/albumin ratio (>= 0.80). The difference between groups was statistically significant (p=0.005). Conclusion: BUN/albumin ratio seems to be a significant prognostic index in NSCLC. It is not only simple but also inexpensive and reproducible. However, it needs further prospective trials with large number of patients. | en_US |
dc.identifier.endpage | 223 | en_US |
dc.identifier.issn | 0393-6384 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 219 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/2839 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000363826100001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Carbone Editore | en_US |
dc.relation.ispartof | Acta Medica Mediterranea | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Blood Urea Nitrogen | en_US |
dc.subject | Albumin | en_US |
dc.subject | Ratio | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Non-small Cell Lung Cancer | en_US |
dc.title | ASSOCIATION BETWEEN BLOOD UREA NITROGEN/ALBUMIN RATIO AND PROGNOSIS IN NON-SMALL CELL LUNG CANCER | en_US |
dc.type | Article | en_US |